HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 47, 44778-44783, November 22, 2002

This Article Abstract Full Text (PDF) All Versions of this Article: 277/47/44778    most recent M206176200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, S.-Y. Articles by Wickner, S. Search for Related Content PubMed PubMed Citation Articles by Kim, S.-Y. Articles by Wickner, S. Social Bookmarking                      What's this?

Interaction of the DnaK and DnaJ Chaperone System with a Native Substrate, P1 RepA^*

Soon-Young Kim, Suveena Sharma, Joel R. Hoskins, and Sue Wickner

From the Laboratory of Molecular Biology, NCI, National Institutes of Health, Bethesda, Maryland 20892

Received for publication, June 20, 2002, and in revised form, September 9, 2002

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

DnaK, the Hsp70 chaperone of Escherichia coli interacts with protein substrates in an ATP-dependent manner, in conjunction with DnaJ and GrpE co-chaperones, to carry out protein folding, protein remodeling, and assembly and disassembly of multisubunit protein complexes. To understand how DnaJ targets specific proteins for recognition by the DnaK chaperone system, we investigated the interaction of DnaJ and DnaK with a known natural substrate, bacteriophage P1 RepA protein. By characterizing RepA deletion derivatives, we found that DnaJ interacts with a region of RepA located between amino acids 180 and 200 of the 286-amino acid protein. A peptide corresponding to amino acids 180-195 inhibited the interaction of RepA and DnaJ. Two site-directed RepA mutants with alanine substitutions in this region were about 4-fold less efficiently activated for oriP1 DNA binding by DnaJ and DnaK than wild type RepA. We also identified by deletion analysis a site in RepA, in the region of amino acids 35-49, which interacts with DnaK. An alanine substitution mutant in amino acids 36-39 was constructed and found defective in activation by DnaJ and DnaK. Taken together the results suggest that DnaJ and DnaK interact with separate sites on RepA.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

DnaK, the Escherichia coli Hsp70 homologue, is an ATP-dependent molecular chaperone that acts in conjunction with the co-chaperones, DnaJ and GrpE, to mediate protein folding and remodeling reactions in the cell. The DnaK and Hsp70 chaperone systems participate in a wide variety of cellular processes in both normal and stressed cells, including nascent protein folding, protein trafficking across intracellular membranes, proteolysis, assembly of multiprotein structures, disassembly of protein aggregates, cell division, DNA replication of several phage and plasmids, and regulation of the heat shock response (see Refs. 1-3 for recent reviews).

Structural studies have shown that DnaK, like other Hsp70s, consists of an N-terminal ATP-binding domain and a C-terminal substrate-binding domain (4, 5). Cycles of ATP binding and hydrolysis by the N-terminal domain modulate peptide binding by DnaK (6-8). In the ATP-bound state, DnaK binds and releases substrates rapidly, whereas in the ADP-bound state, binding and release is slow (9, 10). DnaJ and GrpE regulate cycling between the two states. DnaJ stimulates DnaK ATPase, forming the ADP state of DnaK, which stably interacts with the polypeptide substrate (11). In addition, DnaJ tags several proteins for recognition by DnaK (23, 43). GrpE is a nucleotide exchange factor, binding to the ATPase domain of DnaK and inducing the exchange of bound ADP with ATP (12, 13).

Studies to elucidate the interaction of DnaK and Hsp70 with peptides showed that the chaperones recognize heptameric extended peptides enriched in hydrophobic residues (14-17). Bukau and co-workers (18) performed an extensive study of more than 4000 cellulose-bound peptides spanning sequences of biologically relevant substrates to identify a consensus DnaK binding motif. The motif consists of a hydrophobic core of four or five residues enriched in Leu and to a lesser extent in Ile, Val, Phe, and Tyr, and two flanking regions enriched in basic residues. These sites occur in proteins, not just biologically relevant proteins, on average every 36 residues (18). The DnaJ binding motif was studied by a similar method and found to consist of a hydrophobic core of about 8 residues enriched for aromatic and large aliphatic hydrophobic residues and arginine (19). Although this motif is slightly different from the DnaK binding motif, DnaJ is able to bind most of the same peptides as DnaK (19). Because of the hydrophobic nature of the motifs, DnaK- and DnaJ-binding sites typically reside in the interior of correctly folded proteins and are only exposed in nascent or unfolded polypeptides.

Identification of the DnaJ and DnaK peptide binding motifs helps explain how the chaperone system can interact with unfolded polypeptides. However, in non-stress conditions DnaK protein comprises more than 1% of the total cell protein and is essential for normal growth (20). DnaK would pose a danger to the cell if it indiscriminately unfolded active proteins or dissociated complexes. One of several characterized reactions that the DnaK chaperone system carries out during non-stress situations is the maintenance of plasmid mini-P1 (21, 22). In vitro, DnaK, DnaJ, and GrpE are required for DNA replication of mini-P1 and their sole function is to activate origin-specific DNA binding by RepA by converting inactive RepA dimers to active monomers (23-26). ClpA, a member of the Clp/Hsp100 family of ATP-dependent molecular chaperones, also activates DNA binding by P1 RepA by converting inactive dimers to active monomers (27). Studies to elucidate substrate recognition by ClpA have shown that it recognizes some substrates through N-terminal motifs and others through C-terminal motifs (28-30). RepA is recognized through a motif near the N terminus, between amino acids 10 and 15 (31). To address the question of how the DnaK chaperone system recognizes specific native substrates, we determined regions within a known substrate, P1 RepA, which are recognized by DnaJ and DnaK.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Materials-- ATP was obtained from Roche Molecular Biochemicals. Restriction endonucleases were obtained from New England BioLabs and polymerase chain reaction reagents were obtained from PerkinElmer Life Sciences. Peptides were synthesized, purified, and analyzed by mass spectrophotometry by Research Genetics Inc. Rabbit anti-DnaJ serum and mouse anti-DnaK monoclonal antibody were obtained from StressGen Biotechnologies. Rabbit anti-RepA serum was produced by Research Genetics Inc. using purified RepA.

Plasmids-- The construction of plasmids expressing N-terminal deletions of RepA, including RepA-(16-286), RepA-(26-286), RepA-(36-286), RepA-(50-286), and RepA-(1-180), was previously described (31). Plasmids expressing C-terminal deletions of RepA were constructed by generating appropriate repA polymerase chain reaction fragments containing 5' NdeI and 3' BamHI sites. The fragments were then ligated into pET19b (Novagen), containing a N-terminal deca-His tag. The sequences of all of mutants were verified by DNA sequencing. ³H-Labeled oriP1 plasmid DNA (3590 cpm/fmol) was prepared as described (25).

Site-directed alanine substitution mutants of wild type RepA-His₆ were constructed using the QuikChange mutagenesis kit (Stratagene) and the protocol recommended by the supplier. In RepA-mut1, amino acids Tyr-190, Val-192, Leu-193, and Leu-194 were changed to alanines, in RepA-mut2, amino acids Leu-193, Leu-194, His-196, and His-197 were converted to alanines, and in RepA-mut3 amino acids Arg-36, Leu-37, Gly-38, and Val-39 were converted to alanines.

Proteins-- DnaJ (32), DnaK (26), GrpE (26), and RepA (23) were purified as described. RepA N-terminal deletion proteins, RepA-(50-286), and alanine substitution mutants were isolated by the method described for RepA (23).

The purity of all proteins was greater than 95% as determined by SDS-PAGE. Protein concentrations are expressed as molar amounts of RepA dimers, DnaJ dimers, DnaK monomers, and GrpE dimers. Protein concentrations were determined by Bradford assay (Bio-Rad) with bovine serum albumin as a standard.

RepA Activation Reaction-- Reaction mixtures (20 µl) contained Buffer A (20 mM Tris·HCl, pH 7.5, 100 mM KCl, 5 mM dithiothreitol, 0.1 mM EDTA, 10% glycerol (v/v)), 10 mM MgOAc, 1 mM ATP, 100 µg/ml bovine serum albumin, 0.05 pmol of RepA, 0.5 pmol of DnaJ, and 10 pmol of DnaK, unless indicated otherwise. After 10 min at 24 °C, calf thymus DNA (1 µg) and 10 fmol of [³H]oriP1 plasmid DNA were added. The mixtures were then filtered through nitrocellulose filters, the filters were washed, and the retained radioactivity was measured. Activation by ClpA was measured in similar reaction mixtures but with 0.5 pmol of ClpA in place of DnaJ and DnaK.

Co-immunoprecipitation, SDS-PAGE, and Western Blot Analysis-- Reaction mixtures (50 µl) contained 1 µM RepA or the RepA derivative, and where indicated, 1 µM DnaJ, and 2 µM DnaK in Buffer A with 5 mM MgOAc, 1 mg/ml bovine serum albumin, and 1 mM ATP. After 10 min at room temperature, 400 µl of Buffer B (50 mM Tris·HCl, pH 7.5, 100 mM NaCl, 0.1% Tween 20) and 1 µl of anti-RepA rabbit serum were added. The mixtures were incubated for 30 min at 4 °C with rocking. Then, 15 µl of a 1:1 (v/v) slurry of protein A-Sepharose (Amersham Biosciences) in Buffer B was added and incubated 30 min at 4 °C with rocking. The resin was collected by centrifugation and washed 4 times with 500 µl of 50 mM Tris·HCl, pH 7.5, 300 mM NaCl, 0.2% Tween 20, and 0.1 mM EDTA. The precipitates were subjected to SDS-PAGE and transferred onto a polyvinylidene difluoride membrane (Applied Biotechnologies) by electroblotting. Following transfer, DnaJ, DnaK, and RepA were detected with specific antibodies using a chemiluminiscence blotting substrate kit (Novex Western Breeze, Invitrogen).

For co-immunoprecipitation experiments using cell extracts, BL21 cells expressing His-tagged RepA or RepA derivatives were lysed by a French pressure cell and then centrifuged at 20,000 × g for 30 min. The soluble extracts (50 µl) were incubated with anti-RepA rabbit serum and processed as above.

Enzyme-linked Immunosorbent Assay-- RepA (5 pmol/well in 50 µl of PBS) was immobilized in 96-well microtiter plates (Corning) by incubating for 1 h at room temperature and then washed three times with 150 µl of PBST (PBS with 0.05% Tween 20). DnaJ was preincubated for 10 min alone or with various peptides in 50 µl of PBSTB (PBST containing 2 mg/ml bovine serum albumin) and added to the wells and incubated for 10 min. The amount of bound DnaJ was determined as follows. The wells were washed three times with 150 µl of PBST and then 50 µl of PBST containing anti-DnaJ rabbit serum was added. After 30 min, the wells were washed three times with 150 µl of PBST and peroxidase-conjugated anti-rabbit IgG (Calbiochem) was used as a secondary antibody. Microtiter plates were scanned using a plate reader (Bio-Rad) and the absorbance at 405 nm was measured.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Recognition of RepA by the DnaJ/DnaK Chaperone System-- To investigate the mechanism of native protein recognition by the DnaK chaperone system, we studied the interaction of DnaK and DnaJ with P1 RepA. DnaK and DnaJ activate the latent P1 ori-specific DNA binding activity of RepA by converting inactive dimers to active monomers (24, 25); GrpE is also required under certain conditions to facilitate nucleotide exchange (26).

We tested N-terminal deletion mutants of RepA for their ability to be activated by the combination of DnaK and DnaJ and found that RepA mutants lacking 5, 10, or 15 amino acids were activated as well as wild type RepA (Fig. 1A and data not shown). A deletion missing 25 amino acids was also activated, but to a lesser extent. However, this derivative was also partially defective in DNA binding following activation by treatment with guanidine HCl, suggesting that its defect was not in chaperone recognition but in DNA recognition (Ref. 31 and data not shown). Deletion derivatives of greater than 25 amino acids were not tested because of their impaired DNA binding activity. In contrast, RepA derivatives lacking 15 N-terminal amino acids were not activated by the ClpA molecular chaperone, whereas derivatives lacking 5 or 10 amino acids were activated (Fig. 1B (31)). The results with the derivatives lacking 15 and 25 amino acids indicate that the DnaJ/DnaK chaperone recognition signal in RepA is C-terminal to amino acid 26 and is distinct from the ClpA recognition motif.

View larger version (22K): [in this window] [in a new window]   Fig. 1.   Activation of N-terminal RepA deletion derivatives. A, activation of DNA binding activity of N-terminal RepA deletion proteins by DnaJ and DnaK as described under "Experimental Procedures." B, activation of DNA binding activity of N-terminal RepA deletion proteins by ClpA as described under "Experimental Procedures."

Identification of the DnaJ Recognition Site in RepA by Deletion Analysis-- To explore the region or regions of RepA recognized by DnaJ, co-immunoprecipitation assays were used to detect DnaJ-RepA interactions. Mixtures containing DnaJ and RepA or a RepA deletion derivative were incubated with RepA antiserum and the immunoprecipitates were subjected to SDS-PAGE followed by Western blot analysis with DnaJ antibody as described under "Experimental Procedures." We found that DnaJ associated with wild type RepA and RepA lacking the N-terminal 49 amino acids, RepA-(50-286), but not with RepA lacking the C-terminal 106 amino acids, RepA-(1-180) (Fig. 2A, compare lanes 2, 4, and 6). These results suggested that a DnaJ recognition signal or signals resides in the C-terminal third of RepA, between amino acids 180 and 286. 

View larger version (47K): [in this window] [in a new window]   Fig. 2.   Interaction of DnaJ and RepA and RepA deletion derivatives. A, RepA or N-terminal RepA derivatives were incubated alone or with DnaJ (lanes 1-6) and then immunoprecipitated with rabbit anti-RepA serum and subjected to SDS-PAGE followed by Western blot analysis with DnaJ antiserum as described under "Experimental Procedures." In lane 7, RepA was omitted from the immunoprecipitation mixture; in lane 8, DnaJ was applied to the gel as a marker. B, association of DnaJ with RepA C-terminal deletion derivatives. For co-immunoprecipitation of DnaJ, a soluble cell extract of each mutant was incubated with rabbit anti-RepA serum and proteins associated with the immunoprecipitates were subjected to SDS-PAGE along with the soluble cell extract alone. DnaJ and RepA derivatives were detected by Western blot analysis using either DnaJ or RepA antiserum as described under "Experimental Procedures." IP, immunoprecipitate; Ext, cell extract.

To locate the DnaJ recognition site in RepA more precisely, we constructed five RepA derivatives containing C-terminal deletions. Immunoprecipitation experiments using RepA antiserum and lysates of cells expressing the various derivatives were performed and RepA and DnaJ were detected by Western blot analysis of the immunoprecipitates. Control experiments showed that the cell lysates contained RepA or a RepA deletion derivative and DnaJ (Fig. 2B, lanes 1-5). Two species of RepA-(1-240) were seen, perhaps the result of degradation. We observed that DnaJ co-immunoprecipitated well with RepA derivatives lacking the C-terminal 26 or 46 amino acids (Fig. 2B, lanes 6 and 7). It co-immunoprecipitated less well with derivatives lacking 66 or 86 amino acids (Fig. 2B, lanes 8 and 9). In contrast, DnaJ was not detected in co-immunoprecipitates with a derivative missing 102 amino acids (Fig. 2B, lane 10). These results suggest that the region in RepA between amino acids 185 and 201 is necessary for the interaction with DnaJ and amino acids in the region of 201-220 contribute to the interaction with DnaJ.

Confirmation of the DnaJ Recognition Site by Peptide Competition-- We performed competition experiments using RepA peptides to verify that DnaJ recognized a site in the region of amino acids 185 and 201. For these experiments five RepA peptides were used, corresponding to RepA amino acids 175-189, 180-195, 185-200, 190-206, and 196-211 (Fig. 3A). Wild type RepA was immobilized in microtiter plate wells and then DnaJ alone or DnaJ that had been mixed with one of the RepA peptides was added to the wells. After washing, DnaJ-RepA complexes were detected by enzyme-linked immunosorbent assay. RepA-(180-195) peptide inhibited the interaction of RepA and DnaJ about 90% and 185-200 peptide was inhibited about 20% (Fig. 3B). With this assay, no inhibition by 175-189, 190-206, and 196-211 peptides was detected. A titration experiment showed that 8 µM RepA-(180-195) peptide inhibited the RepA-DnaJ interaction about 50% (Fig. 3C). These results suggest that a DnaJ-binding site resides between amino acids 180 and 200 of RepA.

View larger version (23K): [in this window] [in a new window]   Fig. 3.   Peptide inhibition of RepA-DnaJ interaction. A, RepA peptide sequences used for inhibition experiments. B, inhibition of RepA-DnaJ interaction by RepA peptides. DnaJ (100 nM) was mixed with various RepA peptides (80 µM), as indicated, for 10 min at 24 °C. Enzyme-linked immunosorbent assay was used to detect DnaJ associated with RepA as described under "Experimental Procedures," using DnaJ antiserum. C, inhibition of RepA-DnaJ complex formation by RepA-(180-195) peptide. RepA-(180-195) peptide was incubated at the indicated concentrations with DnaJ (50 nM) for 10 min at 24 °C and RepA-DnaJ complex formation was measured as above. Results are mean (± S.E.) of three independent experiments. The apparent Ki measured by this assay may not reflect that in solution.

Site-directed Mutants in the DnaJ-binding Region of RepA Are Defective in DnaJ/DnaK-mediated Activation-- A potential problem with the experiments using deletion derivatives was that the proteins may have been misfolded and their lack of interaction with DnaJ may not have reflected the disruption of a true DnaJ-binding site in native RepA. Thus, to substantiate the results of the deletion analysis and peptide inhibition studies, two site-directed mutants were constructed in the region identified by the peptide inhibition experiments. In one mutant, RepA-mut1, alanines were substituted for Tyr-190, Val-192, Leu-193, and Leu-194. In the other, RepA-mut2, Leu-193, Leu-194, His-196, and His-197 were replaced with alanines. We tested the ability of these mutants to be activated by the DnaJ/DnaK system (Fig. 4A). Both mutants were 3-4-fold less efficiently activated for oriP1 DNA binding by DnaJ and DnaK than wild type RepA. In contrast, ClpA activated oriP1 DNA binding by both of the mutants to a similar extent as wild type, suggesting that the mutant proteins are native dimers and can refold into active monomers (Fig. 4B). DNA binding by the mutant proteins was also activated to a similar extent as wild type RepA by treatment with 6 M urea followed by dilution (data not shown). These observations suggest that RepA-mut1 and RepA-mut2 are specifically defective in their ability to be remodeled by DnaJ and DnaK and imply that residues important for recognition are in amino acids 190-197. Because RepA-(190-206) peptide did not appear to interact with DnaJ, it is possible that necessary features of the site are in the region of amino acids 180-190 as well as in the region of 190-197. Taken together, the results of the deletion analysis, the peptide inhibition studies, and the site-directed mutant work indicate that a DnaJ interaction site in RepA is in the region of amino acids 180-200.

View larger version (27K): [in this window] [in a new window]   Fig. 4.   Activation by of RepA derivatives with mutations in the DnaJ binding. A, activation of oriP1 DNA binding of RepA and potential RepA DnaJ-binding site mutants by DnaJ and DnaK. B, activation of RepA and RepA mutants by ClpA. Activation reactions were carried out as described under "Experimental Procedures" using ClpA or DnaJ/DnaK and RepA (filled squares), RepA-mut1 (filled circles), or RepA-mut2 (filled triangles). In control experiments, DNA binding by RepA (open squares), RepA-mut1 (open circles), and RepA-mut2 (open triangles) was measured in the absence of chaperones. Results are mean (± S.E.) of three independent experiments.

Location of a DnaK Recognition Site in RepA-- When the immunoprecipitates generated by treating lysates of cells expressing C-terminal RepA derivatives with RepA antiserum (described in Fig. 2B) were probed for DnaK by Western blot analysis, DnaK could be seen associated with all of the C-terminal deletion proteins, although somewhat less appeared to associate with RepA-(1-184), RepA-(1-201), and RepA-(1-220) (Fig. 5A, lanes 4, 6, 8, 10, and 12). In a control experiment, DnaK was not detected when a lysate that did not express a RepA derivative was used (Fig. 5A, lane 2). Thus, DnaK appears to interact with one or more sites in the N-terminal 184 amino acids of RepA. Association of DnaK with RepA-(1-184), which does not interact with DnaJ, indicates that DnaK and DnaJ interact with separate motif/motifs on RepA, although previous work has shown that many peptides that bind DnaK also bind DnaJ (19).

View larger version (37K): [in this window] [in a new window]   Fig. 5.   Interaction of DnaK with RepA and RepA deletion derivatives. A, association of DnaK with RepA C-terminal deletion derivatives. Immunoprecipitation of extracts of cells expressing no RepA or a RepA derivative was performed using RepA antiserum and subjected to SDS-PAGE. DnaK was detected by Western blot analysis using DnaK antibody as described under "Experimental Procedures" (even-numbered lanes). IP, immunoprecipitate; Ext, cell extract. B, interaction of DnaK with RepA N-terminal deletion derivatives. Co-immunoprecipitation of DnaK and purified RepA N-terminal deletion proteins was carried out as described under "Experimental Procedures" using RepA antiserum. DnaK and RepA N-terminal deletion derivatives were detected by Western blot analysis.

To identify a region in the N-terminal portion of RepA recognized by DnaK, we tested purified N-terminal RepA deletion derivatives in the co-immunoprecipitation assay, using RepA antiserum, for their ability to associate with DnaK. DnaK interacted with RepA derivatives lacking 25 and 35 N-terminal amino acids (Fig. 5B, lanes 2 and 3). Interaction of DnaK with the 25-amino acid deletion mutant substantiated the result that mutant could be activated for DNA binding by the DnaK chaperone system (Fig. 1A). In contrast, no detectable binding was seen between DnaK and a mutant RepA lacking 49 N-terminal amino acids, RepA-(50-286), although that mutant bound DnaJ (Fig. 2A). This result suggested that there is a DnaK-binding site in RepA in the vicinity of amino acids 36-49 (Fig. 5B, lane 4). The sequence in that region is: ³⁶RLGVFVPKPSKSKG⁴⁹.

We then made an alanine substitution mutant, RepA-mut3, in which Arg-36, Leu-37, Gly-38, and Val-39 were replaced with alanines by site-directed mutagenesis. The mutant was not detectably activated by DnaJ and DnaK, because the amount of DNA binding seen in the absence and presence of the chaperone system was similar (Fig. 6). The mutant was activated by ClpA, indicating that the structure of the mutant protein was similar to wild type in being recognized by ClpA and converted to active monomers capable of binding DNA (Fig. 6). These results suggest that the alanine substitutions disrupt a necessary recognition signal.

View larger version (21K): [in this window] [in a new window]   Fig. 6.   Activation of a RepA derivative with alanine substitutions in the potential DnaK-binding site. RepA-mut3 was assayed for activation by DnaJ/DnaK (filled squares) and ClpA (filled circles) as described under "Experimental Procedures." DNA binding in the absence of molecular chaperones (open triangles) was also measured.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

We have studied the interaction of DnaJ and DnaK with RepA to understand how the DnaK chaperone system recognizes a native protein. The experiments to locate DnaJ recognition sites in RepA by co-immunoprecipitation, peptide inhibition, and site-directed mutation identified a DnaJ-binding site in the region of amino acids 180-200. That 20-amino acid region of RepA contains 13 amino acids expected to be found in peptides that bind DnaJ (19). The peptide that inhibited the interaction of DnaJ and RepA to the greatest extent, RepA-(180-195), contains nine residues expected to be found in a DnaJ binding motif within a stretch of 13 amino acids (Fig. 3A). The RepA-(185-200) peptide contains nine expected amino acids in a span of 16 amino acids. However, it inhibited RepA-DnaJ binding significantly less well than the 180-195 peptide. The results presented here show that there is a DnaK-binding site in RepA between amino acids 35 and 49. The probable site in RepA, based on characterization of peptide binding by DnaK by Bukau and co-workers (18), consists of a core of five hydrophobic amino acids between residues 37 and 41, LGVFV, and several flanking basic amino acids, Arg-36, Lys-43, and Lys-46.

Previous work showed that many peptides that bind DnaJ also bind DnaK (19). The observation that DnaK bound RepA with a C-terminal deletion of 102 amino acids but DnaJ did not (Figs. 2B and 5A), suggests that DnaK can bind to a site or sites in RepA distinct from DnaJ sites. The observation that RepA deleted for the N-terminal 49 amino acids bound DnaJ but not DnaK (Figs. 2A and 5B), indicates that the DnaJ-binding site or sites in RepA are specific for DnaJ and not bound by DnaK. It is possible that the sites identified by the deletion analysis reflected hydrophobic regions exposed because of misfolding of the deletion derivatives. However, both peptide competition experiments and site-directed mutations further suggested that these regions are important for recognition by the DnaJ and DnaK chaperone system.

Two mechanisms have been proposed for the targeting of substrates to DnaK by DnaJ (19). In both, DnaJ initially binds to the substrate through specific DnaJ-binding sites. By the first mechanism, the DnaJ- and DnaK-binding sites on the substrate are one and the same. Binding of DnaK·ATP to the substrate is concurrent with the dissociation of DnaJ from the substrate and the association of DnaJ with DnaK, in a reaction involving DnaJ- and substrate-dependent ATP hydrolysis by DnaK. In the second mechanism, DnaK associates with a different site on the substrate than DnaJ, generating a ternary complex stabilized by substrate-DnaJ, substrate-DnaK, and DnaJ-DnaK interactions following DnaJ- and substrate-dependent ATP hydrolysis by DnaK. Both models suggest that ADP/ATP exchange, stimulated by GrpE, results in conformational changes in DnaK that cause release of the substrate. Our data supports the second mechanism in which RepA recruits the DnaK chaperone system by specifically and separately interacting with DnaJ and DnaK.

The number of known natural substrates for the DnaK chaperone system is small and their interaction with DnaJ and DnaK has not been characterized extensively. The DNA replication initiation complex of bacteriophage , DnaB-P-O-ori DNA, is remodeled by the DnaK chaperone system in a reaction involving the release of P and some O and resulting in the activation of DnaB helicase and DNA replication (34). Studies with purified proteins have demonstrated that both O and P interact with DnaJ and DnaK (34-36). The initiator proteins of plasmids F and RK2 are activated and monomerized by DnaJ and DnaK, very likely by a mechanism similar to P1 RepA (37, 38). In the case of the RK2 initiator, the reaction requires an additional molecular chaperone, ClpB (38). The DnaK chaperone system also acts on the heat shock  factor, ³², to facilitate its degradation (39) and in vitro ³² interacts with both DnaJ and DnaK (35, 40). Further work is necessary to establish whether DnaK and DnaJ generally recognize separate sites on specific substrates as suggested by the work presented here with RepA.

	FOOTNOTES

^* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Bldg. 37, Rm. 5144, NCI, National Institutes of Health, 37 Convent Dr., MSC37-4264, Bethesda, MD 20892-4264. Tel.: 301-496-2629; Fax: 301-402-1344; E-mail: suewick@helix.nih.gov.

Published, JBC Papers in Press, September 16, 2002, DOI 10.1074/jbc.M206176200

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

1.	Frydman, J. (2001) Annu. Rev. Biochem. 70, 603-647[CrossRef][Medline] [Order article via Infotrieve]
2.	Bukau, B., and Horwich, A. L. (1998) Cell 92, 351-366[CrossRef][Medline] [Order article via Infotrieve]
3.	Bukau, B., Deuerling, E., Pfund, C., and Craig, E. A. (2000) Cell 101, 119-122[CrossRef][Medline] [Order article via Infotrieve]
4.	Flaherty, K. M., DeLuca-Flaherty, C., and McKay, D. B. (1990) Nature 346, 623-628[CrossRef][Medline] [Order article via Infotrieve]
5.	Zhu, X., Zhao, X., Burkholder, W. F., Gragerov, A., Ogata, C. M., Gottesman, M. E., and Hendrickson, W. A. (1996) Science 272, 1606-1614[Abstract]
6.	Szabo, A., Langer, T., Schroder, H., Flanagan, J., Bukau, B., and Hartl, F. U. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10345-10349[Abstract/Free Full Text]
7.	Laufen, T., Mayer, M. P., Beisel, C., Klostermeier, D., Mogk, A., Reinstein, J., and Bukau, B. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 5452-5457[Abstract/Free Full Text]
8.	Mayer, M. P., Rudiger, S., and Bukau, B. (2000) Biol. Chem. 381, 877-885[CrossRef][Medline] [Order article via Infotrieve]
9.	Schmid, D., Baici, A., Gehring, H., and Christen, P. (1994) Science 263, 971-973[Abstract/Free Full Text]
10.	Russell, R., Wali Karzai, A., Mehl, A. F., and McMacken, R. (1999) Biochemistry 38, 4165-4176[CrossRef][Medline] [Order article via Infotrieve]
11.	McCarty, J. S., Buchberger, A., Reinstein, J., and Bukau, B. (1995) J. Mol. Biol. 249, 126-137[CrossRef][Medline] [Order article via Infotrieve]
12.	Harrison, C. J., Hayer-Hartl, M., Di, Liberto, M., Hartl, F., and Kuriyan, J. (1997) Science 276, 431-435[Abstract/Free Full Text]
13.	Packschies, L., Theyssen, H., Buchberger, A., Bukau, B., Goody, R. S., and Reinstein, J. (1997) Biochemistry 36, 3417-3422[CrossRef][Medline] [Order article via Infotrieve]
14.	Flynn, G. C., Pohl, J., Flocco, M. T., and Rothman, J. E. (1991) Nature 353, 726-730[CrossRef][Medline] [Order article via Infotrieve]
15.	Landry, S. J., Jordan, R., McMacken, R., and Gierasch, L. M. (1992) Nature 355, 455-457[CrossRef][Medline] [Order article via Infotrieve]
16.	Blond-Elguindi, S., Cwirla, S. E., Dower, W. J., Lipshutz, R. J., Sprang, S. R., Sambrook, J. F., and Gething, M. J. (1993) Cell 75, 717-728[CrossRef][Medline] [Order article via Infotrieve]
17.	Gragerov, A., Zeng, L., Zhao, X., Burkholder, W., and Gottesman, M. E. (1994) J. Mol. Biol. 235, 848-854[CrossRef][Medline] [Order article via Infotrieve]
18.	Rudiger, S., Germeroth, L., Schneider-Mergener, J., and Bukau, B. (1997) EMBO J. 16, 1501-1507[CrossRef][Medline] [Order article via Infotrieve]
19.	Rudiger, S., Schneider-Mergener, J., and Bukau, B. (2001) EMBO J. 20, 1042-1050[CrossRef][Medline] [Order article via Infotrieve]
20.	Bukau, B., and Walker, G. C. (1989) J. Bacteriol. 171, 2337-2346[Abstract/Free Full Text]
21.	Bukau, B., and Walker, G. C. (1989) J. Bacteriol. 171, 6030-6038[Abstract/Free Full Text]
22.	Tilly, K., and Yarmolinsky, M. (1989) J. Bacteriol. 171, 6025-6029[Abstract/Free Full Text]
23.	Wickner, S. H. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 2690-2694[Abstract/Free Full Text]
24.	Wickner, S., Hoskins, J., and McKenney, K. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7903-7907[Abstract/Free Full Text]
25.	Wickner, S., Hoskins, J., and McKenney, K. (1991) Nature 350, 165-167[CrossRef][Medline] [Order article via Infotrieve]
26.	Skowyra, D., and Wickner, S. (1993) J. Biol. Chem. 268, 25296-25301[Abstract/Free Full Text]
27.	Wickner, S., Gottesman, S., Skowyra, D., Hoskins, J., McKenney, K., and Maurizi, M. R. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 12218-12222[Abstract/Free Full Text]
28.	Tobias, J. W., Shrader, T. E., Rocap, G., and Varshavsky, A. (1991) Science 254, 1374-1377[Abstract/Free Full Text]
29.	Gottesman, S., Roche, E., Zhou, Y., and Sauer, R. T. (1998) Genes Dev. 12, 1338-1347[Abstract/Free Full Text]
30.	Hoskins, J. R., Singh, S. K., Maurizi, M. R., and Wickner, S. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 8892-8897[Abstract/Free Full Text]
31.	Hoskins, J. R., Kim, S. Y., and Wickner, S. (2000) J. Biol. Chem. 275, 35361-35367[Abstract/Free Full Text]
32.	Zylicz, M., Yamamoto, T., McKittrick, N., Sell, S., and Georgopoulos, C. (1985) J. Biol. Chem. 260, 7591-7598[Abstract/Free Full Text]
33.	Hoskins, J. R., Pak, M., Maurizi, M. R., and Wickner, S. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12135-12140[Abstract/Free Full Text]
34.	Alfano, C., and McMacken, R. (1989) J. Biol. Chem. 264, 10699-10708[Abstract/Free Full Text]
35.	Wawrzynow, A., and Zylicz, M. (1995) J. Biol. Chem. 270, 19300-19306[Abstract/Free Full Text]
36.	Wawrzynow, A., Banecki, B., Wall, D., Liberek, K., Georgopoulos, C., and Zylicz, M. (1995) J. Biol. Chem. 270, 19307-19311[Abstract/Free Full Text]
37.	Ishiai, M., Wada, C., Kawasaki, Y., and Yura, T. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 3839-3843[Abstract/Free Full Text]
38.	Konieczny, I., and Liberek, K. (2002) J. Biol. Chem. 277, 18483-18488[Abstract/Free Full Text]
39.	Straus, D., Walter, W., and Gross, C. A. (1990) Genes Dev. 4, 2202-2209[Abstract/Free Full Text]
40.	Gamer, J., Bujard, H., and Bukau, B. (1992) Cell 69, 833-842[CrossRef][Medline] [Order article via Infotrieve]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A. Nakamura, C. Wada, and K. Miki Structural basis for regulation of bifunctional roles in replication initiator protein PNAS, November 20, 2007; 104(47): 18484 - 18489. [Abstract] [Full Text] [PDF]

				C. Y. Yoo, K. Miura, J. B. Jin, J. Lee, H. C. Park, D. E. Salt, D.-J. Yun, R. A. Bressan, and P. M. Hasegawa SIZ1 Small Ubiquitin-Like Modifier E3 Ligase Facilitates Basal Thermotolerance in Arabidopsis Independent of Salicylic Acid Plant Physiology, December 1, 2006; 142(4): 1548 - 1558. [Abstract] [Full Text] [PDF]

				R. K. Siegenthaler and P. Christen Tuning of DnaK Chaperone Action by Nonnative Protein Sensor DnaJ and Thermosensor GrpE J. Biol. Chem., November 10, 2006; 281(45): 34448 - 34456. [Abstract] [Full Text] [PDF]

				N. S. Cintron and D. Toft Defining the Requirements for Hsp40 and Hsp70 in the Hsp90 Chaperone Pathway J. Biol. Chem., September 8, 2006; 281(36): 26235 - 26244. [Abstract] [Full Text] [PDF]

				A. J. Andrew, R. Dutkiewicz, H. Knieszner, E. A. Craig, and J. Marszalek Characterization of the Interaction between the J-protein Jac1p and the Scaffold for Fe-S Cluster Biogenesis, Isu1p J. Biol. Chem., May 26, 2006; 281(21): 14580 - 14587. [Abstract] [Full Text] [PDF]

				A. M. Breier, H.-U. G. Weier, and N. R. Cozzarelli Independence of replisomes in Escherichia coli chromosomal replication PNAS, March 15, 2005; 102(11): 3942 - 3947. [Abstract] [Full Text] [PDF]

				S. Sharma, J. R. Hoskins, and S. Wickner Binding and Degradation of Heterodimeric Substrates by ClpAP and ClpXP J. Biol. Chem., February 18, 2005; 280(7): 5449 - 5455. [Abstract] [Full Text] [PDF]

				M. M. Abhyankar, J. M. Reddy, R. Sharma, E. Bullesbach, and D. Bastia Biochemical Investigations of Control of Replication Initiation of Plasmid R6K J. Biol. Chem., February 20, 2004; 279(8): 6711 - 6719. [Abstract] [Full Text] [PDF]

				S. Sharma, B. K. Sathyanarayana, J. G. Bird, J. R. Hoskins, B. Lee, and S. Wickner Plasmid P1 RepA Is Homologous to the F Plasmid RepE Class of Initiators J. Biol. Chem., February 13, 2004; 279(7): 6027 - 6034. [Abstract] [Full Text] [PDF]

				W. Han and P. Christen Mechanism of the Targeting Action of DnaJ in the DnaK Molecular Chaperone System J. Biol. Chem., May 23, 2003; 278(21): 19038 - 19043. [Abstract] [Full Text] [PDF]

				P. Bischofberger, W. Han, B. Feifel, H.-J. Schonfeld, and P. Christen D-Peptides as Inhibitors of the DnaK/DnaJ/GrpE Chaperone System J. Biol. Chem., May 23, 2003; 278(21): 19044 - 19047. [Abstract] [Full Text] [PDF]

				T. Diaz-Lopez, M. Lages-Gonzalo, A. Serrano-Lopez, C. Alfonso, G. Rivas, R. Diaz-Orejas, and R. Giraldo Structural Changes in RepA, a Plasmid Replication Initiator, upon Binding to Origin DNA J. Biol. Chem., May 9, 2003; 278(20): 18606 - 18616. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 277/47/44778    most recent M206176200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, S.-Y. Articles by Wickner, S. Search for Related Content PubMed PubMed Citation Articles by Kim, S.-Y. Articles by Wickner, S. Social Bookmarking